Royal Philips (PHG) and Medtronic Neurovascular announced a strategic advocacy partnership. As leaders in stroke diagnosis and treatment, the two organizations are advocating on raising awareness around the potential health and economic benefits for patients, their families and societies of improving access to timely stroke diagnosis and treatment.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHG:
- Philips showcases next level cardiology innovations at TCT 2024
- Philips upgraded to Outperform from Neutral at Oddo BHF
- Philips, Siloam Hospitals Group sign AI capability MoU
- Philips price target raised to EUR 28.50 from EUR 26.50 at Citi
- Philips, Jackson Health System announces results of collaborative LCA